Metoprolol Succinate Extended Release Tablets

País: Nueva Zelanda

Idioma: inglés

Fuente: Medsafe (Medicines Safety Authority)

Ingredientes activos:

Metoprolol succinate 23.75mg equivalent to metoprolol tartrate 25mg

Disponible desde:

AFT Pharmaceuticals Ltd

Designación común internacional (DCI):

Metoprolol succinate 23.75 mg (equivalent to metoprolol tartrate 25mg)

Dosis:

23.75 mg

formulario farmacéutico:

Modified release tablet

Composición:

Active: Metoprolol succinate 23.75mg equivalent to metoprolol tartrate 25mg Excipient: Cellulose acetate Crospovidone Glyceryl monostearate Hypromellose Methacrylic acid copolymer Microcrystalline cellulose Opadry clear YS-1-7006 Opadry white YS-1-7003 Poloxamer 188 Polysorbate 80 Sugar spheres

tipo de receta:

Prescription

Fabricado por:

Watson Pharma Private Limited

indicaciones terapéuticas:

Metoprolol Succinate Extended-Release Tablets are indicated for the treatment of: Hypertension - to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.

Resumen del producto:

Package - Contents - Shelf Life: Bottle, plastic, HDPE bottle with PP cap - 100 tablets - 36 months from date of manufacture stored at or below 25°C

Fecha de autorización:

2016-06-24